Joseph Kaserman, MD, Instructor in the Section of Pulmonary, Allergy, Sleep and Critical Care, received the inaugural John W. Walsh Translational Research Award in Alpha-1 Antitrypsin Deficiency. The award is named in honor of John W. Walsh, the co founder of the Alpha-1 Foundation, who dedicated his life to finding a cure for Alpha-1 Antitrypsin Deficiency and helping those afflicted by it. Kaserman will be using the $225,000 award ($75,000 over three years) to study whether Alpha-1 carriers (individuals who have one normal Alpha1 gene (M) and one mutated gene (Z)), have an increased risk of developing liver disease. Alpha-1 is a genetic (inherited) condition, passed from parents to their children through their genes. It may result in serious lung disease in adults and/or liver disease at any age and up to 2% of the U.S. population could be an Alpha-1 carrier.
Congratulations to Dr. Kaserman!